Past posts from Tylenol’s official X account have resurfaced this week, drawing attention after the White House issued new guidance on acetaminophen use during pregnancy.
The tweets, dating back to 2017 and 2019, cautioned that the company had not formally tested its products for prenatal use.
One March 2017 post stated, “We actually don’t recommend using any of our products while pregnant. Thank you for taking the time to voice your concerns today.”
Another post from June 2019 congratulated a woman on her pregnancy while noting the company had not evaluated Tylenol for use during pregnancy.
These messages, discovered by social media users, have circulated widely after the account, inactive since 2021, was revisited online, Breitbart reports.
The renewed attention followed an announcement Monday from President Donald Trump, accompanied by Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz.
Resist the Mainstream noted that the administration advised pregnant women to limit acetaminophen intake, particularly for nonessential use, citing studies suggesting a potential link to autism.
“For this reason, they are strongly recommending that women limit Tylenol use during pregnancy, unless medically necessary,” the White House said.
Social media response was immediate, with some pregnant women posting videos of themselves taking Tylenol to challenge the guidance.
One pregnant woman captioned a clip, “I believe in science and not someone who has no medical background.”
Commentators on conservative platforms highlighted these reactions as dismissive of possible health risks for political reasons, illustrating how public health guidance can become politicized.
Kenvue, the manufacturer of Tylenol, responded to the renewed scrutiny by emphasizing that acetaminophen remains generally safe when taken under medical supervision.
“We believe independent, sound science clearly shows that taking acetaminophen does not cause autism,” a spokesperson said, noting that the earlier tweets reflected limited consumer guidance rather than comprehensive safety recommendations.
Current labeling advises pregnant or breastfeeding women to consult healthcare professionals before using the medication.
Medical experts stressed the importance of following professional advice during pregnancy.
Dr. Nechama Sorscher, a pediatric neuropsychologist in New York, stated, “Research on acetaminophen and autism does not prove definitive causation.”
Dr. Gail Saltz, a psychiatry professor at Weill Cornell Medical College, noted that managing fevers in pregnant women is critical to fetal health and that acetaminophen remains widely recommended for that purpose, per the Daily Mail.
The Centers for Disease Control and Prevention report that approximately one in 31 children in the United States now has an autism diagnosis, highlighting ongoing concern over environmental and medical contributors.
The White House framed its advisory as part of broader efforts to investigate factors influencing autism prevalence.
Observers note that older corporate messages can gain renewed relevance when amplified in politically charged environments.
Tylenol’s decade-old posts have sparked debate over pregnancy safety, public health guidance and the role of social media in shaping public perception.
Analysts say the episode illustrates how digital communications can resurface and influence discussions far beyond their original intent.
This development underscores the need for careful evaluation of medical guidance, responsible social media sharing and reliance on healthcare professionals for decision-making during pregnancy.
The Tylenol posts, Trump administration advisory and public reaction together reflect the complex intersection of health information, politics and viral content.
